[Clinical experience with propericiazine or an adjuvant in the therapy of epileptic syndromes].
D000293:Adolescent; D000328:Adult; D004357:Drug Synergism; D004569:Electroencephalography; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy*; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy*; D005013:Ethosuximide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use*; D010640:Phenothiazines / Q000627:therapeutic use*; D010672:Phenytoin / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D009570:Nitriles; D010640:Phenothiazines; D010880:Piperidines; D014149:Tranquilizing Agents; D005013:Ethosuximide; D010672:Phenytoin
Esperienze cliniche con la propericiazina come coadiuvante della terapia delle sindromi epilettiche.